Gullik Håkan Wickholm
Directeur/Bestuurslid bij Beactica Therapeutics AB
Actieve functies van Gullik Håkan Wickholm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Directeur/Bestuurslid | 01-01-2018 | - |
GHW Consulting AB | Directeur/Bestuurslid | - | - |
Loopbaan van Gullik Håkan Wickholm
Eerdere bekende functies van Gullik Håkan Wickholm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AstraZeneca AS | Corporate Officer/Principal | - | - |
GENOVIS AB | Directeur/Bestuurslid | 01-01-2019 | - |
LYTIX BIOPHARMA | Algemeen Directeur | 01-01-2014 | 07-09-2017 |
Corporate Officer/Principal | 07-09-2017 | - |
Opleiding van Gullik Håkan Wickholm
University of Uppsala | Undergraduate Degree |
Statistieken
Internationaal
Zweden | 5 |
Noorwegen | 3 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
LYTIX BIOPHARMA | Health Technology |
GENOVIS AB | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
GHW Consulting AB |